We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
(+98%)
Cap. Flow
+$1.94B
Cap. Flow
% of AUM
50.99%
Top 10 Holdings %
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$25.6M |
| 2 |
JPMorgan Chase
JPM
|
+$21.7M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$19.7M |
| 4 |
Kroger
KR
|
+$17.9M |
| 5 |
T-Mobile US
TMUS
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$11.3M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$8.42M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$8.34M |
| 4 |
Cisco
CSCO
|
+$8.02M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$8.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.84% |
| 2 | Technology | 16.54% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 11.32% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Arts-Way Manufacturing Co
ARTW
$11.1M
| $51.2K | ﹤0.01% |
+21,776
| New | +$53.5K |
|
|
ORBS
2827
Eightco Holdings
ORBS
$230M
| $51K | ﹤0.01% |
+29,506
| New | +$139K |
|
2828
Palisade Bio
PALI
$342M
| $50.9K | ﹤0.01% |
21,669
+7,584
| +54% | +$14.6K |
|
|
ZOOZ
2829
ZOOZ Strategy Ltd
ZOOZ
$41.1M
| $50.9K | ﹤0.01% |
5,807
+5,273
| +987% | +$106K |
|
|
OLPX
2830
DELISTED
Olaplex Holdings
OLPX
| $50.8K | ﹤0.01% |
37,944
-32,645
| -46% | -$38.8K |
|
2831
Koss Corp
KOSS
$34.6M
| $50.4K | ﹤0.01% |
+12,185
| New | +$58.5K |
|
|
FARM
2832
DELISTED
Farmer Brothers
FARM
| $50.3K | ﹤0.01% |
34,442
+12,470
| +57% | +$20.1K |
|
2833
Cognition Therapeutics
CGTX
$81.8M
| $50.3K | ﹤0.01% |
+37,227
| New | +$60.4K |
|
|
SDM
2834
DELISTED
Smart Digital Group
SDM
| $49.9K | ﹤0.01% |
26,956
| – | – |
|
2835
DocGo
DCGO
$66.2M
| $49.6K | ﹤0.01% |
56,513
-53,909
| -49% | -$57.6K |
|
2836
Cosmos Holdings
COSM
$11.6M
| $49.6K | ﹤0.01% |
99,610
+34,117
| +52% | +$25.4K |
|
2837
Acrivon Therapeutics
ACRV
$61.6M
| $49.6K | ﹤0.01% |
20,572
-15,383
| -43% | -$33.4K |
|
2838
System1
SST
$14.5M
| $48.5K | ﹤0.01% |
12,376
-128
| -1% | -$662 |
|
2839
Frontier Group Holdings
ULCC
$1.51B
| $48.4K | ﹤0.01% |
10,277
-128,601
| -93% | -$570K |
|
2840
TELA Bio
TELA
$30.3M
| $48.3K | ﹤0.01% |
+40,955
| New | +$51.8K |
|
|
EONR
2841
EON Resources
EONR
$24.9M
| $48.2K | ﹤0.01% |
125,585
+37,015
| +42% | +$17.4K |
|
|
UHG
2842
DELISTED
United Homes Group
UHG
| $48K | ﹤0.01% |
30,781
-24,375
| -44% | -$47.3K |
|
2843
ICZOOM Group
IZM
$2.89M
| $47.9K | ﹤0.01% |
+18,846
| New | +$30K |
|
2844
Outlook Therapeutics
OTLK
$184M
| $47.8K | ﹤0.01% |
30,224
+19,214
| +175% | +$30.7K |
|
|
PURR
2845
Hyperliquid Strategies Inc
PURR
$1.2B
| $47.8K | ﹤0.01% |
+13,414
| New | +$46.5K |
|
|
IRD
2846
Opus Genetics
IRD
$287M
| $47.7K | ﹤0.01% |
23,737
-28,020
| -54% | -$56.9K |
|
2847
Traws Pharma
TRAW
$7.45M
| $47.7K | ﹤0.01% |
42,210
+31,502
| +294% | +$70.1K |
|
|
BRR
2848
ProCap Financial Inc
BRR
$152M
| $47.6K | ﹤0.01% |
+13,485
| New | +$108K |
|
|
GXAI
2849
Gaxos.ai
GXAI
$9.12M
| $47.5K | ﹤0.01% |
44,811
+29,745
| +197% | +$42.3K |
|
2850
China Automotive Systems
CAAS
$130M
| $47.5K | ﹤0.01% |
+11,150
| New | +$47.7K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q4 2025 Portfolio in Review
As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.
XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.
- XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
- XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
- XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
- XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
- XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
- XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
- XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.
Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.